Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Geraldine Perkins"'
Autor:
Guillaume Perrod, Elia Samaha, Gabriel Rahmi, Sherine Khater, Leila Abbes, Camille Savale, Geraldine Perkins, Aziz Zaanan, Gilles Chatellier, Georgia Malamut, Christophe Cellier
Publikováno v:
Therapeutic Advances in Gastroenterology, Vol 11 (2018)
Background: Despite colonoscopic screening, colorectal cancer (CRC) remains frequent in patients with Lynch syndrome (LS). The objective of this study was to evaluate the impact of an optimized colorectal screening program within a French dedicated n
Externí odkaz:
https://doaj.org/article/37bba10f17e342f793cbcc6621cb189d
Autor:
Geraldine Perkins, Timothy A Yap, Lorna Pope, Amy M Cassidy, Juliet P Dukes, Ruth Riisnaes, Christophe Massard, Philippe A Cassier, Susana Miranda, Jeremy Clark, Katie A Denholm, Khin Thway, David Gonzalez De Castro, Gerhardt Attard, L Rhoda Molife, Stan B Kaye, Udai Banerji, Johann S de Bono
Publikováno v:
PLoS ONE, Vol 7, Iss 11, p e47020 (2012)
Tumor genomic instability and selective treatment pressures result in clonal disease evolution; molecular stratification for molecularly targeted drug administration requires repeated access to tumor DNA. We hypothesized that circulating plasma DNA (
Externí odkaz:
https://doaj.org/article/3dec2081d85c4d8ca5a5e0e4c2fc16a1
Autor:
Lubka T. Roumenina, Wolf H. Fridman, Catherine Sautès-Fridman, Isabelle Cremer, Veronique Fremeaux-Bacchi, Diane Damotte, Rafael Sanchez-Salas, Xavier Cathelineau, Pierre Validire, Geraldine Perkins, Yann A. Vano, Arnaud Mejean, Stephane M. Oudard, Virginie Verkarre, Maxime Meylan, Antoine Bougouin, Guillaume Lacroix, Anne Grunenwald, Victoria Poillerat, Tania Robe-Rybkine, Christine Gaboriaud, Marie-Agnès Dragon-Durey, Jules Russick, Margot Revel, Marie V. Daugan
Supplementary Figures 1-15
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3fb295f5109a7bea61aaebb35b149081
https://doi.org/10.1158/2326-6066.22544075
https://doi.org/10.1158/2326-6066.22544075
Autor:
Lubka T. Roumenina, Wolf H. Fridman, Catherine Sautès-Fridman, Isabelle Cremer, Veronique Fremeaux-Bacchi, Diane Damotte, Rafael Sanchez-Salas, Xavier Cathelineau, Pierre Validire, Geraldine Perkins, Yann A. Vano, Arnaud Mejean, Stephane M. Oudard, Virginie Verkarre, Maxime Meylan, Antoine Bougouin, Guillaume Lacroix, Anne Grunenwald, Victoria Poillerat, Tania Robe-Rybkine, Christine Gaboriaud, Marie-Agnès Dragon-Durey, Jules Russick, Margot Revel, Marie V. Daugan
The complement system plays a complex role in cancer. In clear cell renal cell carcinoma (ccRCC), local production of complement proteins drives tumor progression, but the mechanisms by which they do this are poorly understood. We found that compleme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5a015140b9f14187f155016759ed8b80
https://doi.org/10.1158/2326-6066.c.6550523.v1
https://doi.org/10.1158/2326-6066.c.6550523.v1
Autor:
Lubka T. Roumenina, Wolf H. Fridman, Catherine Sautès-Fridman, Isabelle Cremer, Veronique Fremeaux-Bacchi, Diane Damotte, Rafael Sanchez-Salas, Xavier Cathelineau, Pierre Validire, Geraldine Perkins, Yann A. Vano, Arnaud Mejean, Stephane M. Oudard, Virginie Verkarre, Maxime Meylan, Antoine Bougouin, Guillaume Lacroix, Anne Grunenwald, Victoria Poillerat, Tania Robe-Rybkine, Christine Gaboriaud, Marie-Agnès Dragon-Durey, Jules Russick, Margot Revel, Marie V. Daugan
Supplementary Tables 1-3
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::61047cf709ebb45aaf4f891c053a7d14
https://doi.org/10.1158/2326-6066.22544072
https://doi.org/10.1158/2326-6066.22544072
Autor:
Aziz Zaanan, Valerie Taly, Frederic Di Fiore, Julien Taieb, Hélène Blons, Claire Mulot, Geraldine Perkins, Pierre Michel, Nasrin Sarafan-Vasseur, Audrey Didelot, Nathalie Siauve, David Sefrioui, Pierre Laurent-Puig, Fanny Garlan
Purpose: Markers of chemotherapy efficacy in metastatic colorectal cancer (mCRC) are essential for optimization of treatment strategies. We evaluated the applicability of early changes in circulating tumor DNA (ctDNA) as a marker of therapeutic effic
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5975726e4b55ff76dff6d106df75d07a
https://doi.org/10.1158/1078-0432.c.6527057
https://doi.org/10.1158/1078-0432.c.6527057
Autor:
Aziz Zaanan, Valerie Taly, Frederic Di Fiore, Julien Taieb, Hélène Blons, Claire Mulot, Geraldine Perkins, Pierre Michel, Nasrin Sarafan-Vasseur, Audrey Didelot, Nathalie Siauve, David Sefrioui, Pierre Laurent-Puig, Fanny Garlan
Supplementary text, Tables and supplementary figure legends Supplementary Table 1. Comparison of clinical variables between patients with no detectable ctDNA versus patients with detectable ctDNA at baseline. Supplementary Table 2: Different multivar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c277cf2ae502c6313cf2de3b169bc3bc
https://doi.org/10.1158/1078-0432.22468799
https://doi.org/10.1158/1078-0432.22468799
Autor:
Aziz Zaanan, Valerie Taly, Frederic Di Fiore, Julien Taieb, Hélène Blons, Claire Mulot, Geraldine Perkins, Pierre Michel, Nasrin Sarafan-Vasseur, Audrey Didelot, Nathalie Siauve, David Sefrioui, Pierre Laurent-Puig, Fanny Garlan
Supplementary Figure 3. Progression free survival (PFS, panel A) and overall survival (OS, Panel B) of metastatic colorectal cancer patients according to variations of ctDNA concentration categorized in three groups: decreasing group with a ctDNA nor
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0aa27087381f70cf5c6eb522b828e350
https://doi.org/10.1158/1078-0432.22468808.v1
https://doi.org/10.1158/1078-0432.22468808.v1
Autor:
Marie-Agnès Dragon-Durey, Virginie Verkarre, Jules Russick, Anne Grunenwald, Yann Vano, Maxime Meylan, Christine Gaboriaud, Stéphane Oudard, Lubka T. Roumenina, Tania Robe-Rybkine, Rafael Sanchez-Salas, Catherine Sautès-Fridman, Marie V. Daugan, Guillaume Lacroix, Pierre Validire, Victoria Poillerat, Diane Damotte, Xavier Cathelineau, Isabelle Cremer, Wolf H. Fridman, A. Mejean, Geraldine Perkins, Antoine Bougoüin, Margot Revel, Véronique Frémeaux-Bacchi
Publikováno v:
Cancer Immunology Research
Cancer Immunology Research, American Association for Cancer Research, 2021, pp.canimm.0532.2020. ⟨10.1158/2326-6066.cir-20-0532⟩
Cancer Immunology Research, American Association for Cancer Research, 2021, 9 (8), pp.891-908. ⟨10.1158/2326-6066.CIR-20-0532⟩
Cancer Immunology Research, 2021, 9 (8), pp.891-908. ⟨10.1158/2326-6066.cir-20-0532⟩
Cancer Immunology Research, American Association for Cancer Research, 2021, pp.canimm.0532.2020. ⟨10.1158/2326-6066.cir-20-0532⟩
Cancer Immunology Research, American Association for Cancer Research, 2021, 9 (8), pp.891-908. ⟨10.1158/2326-6066.CIR-20-0532⟩
Cancer Immunology Research, 2021, 9 (8), pp.891-908. ⟨10.1158/2326-6066.cir-20-0532⟩
The complement system plays a complex role in cancer. In clear cell renal cell carcinoma (ccRCC), local production of complement proteins drives tumor progression, but the mechanisms by which they do this are poorly understood. We found that compleme
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e877b86f32c215690799537132392773
https://hal.sorbonne-universite.fr/hal-03241408/document
https://hal.sorbonne-universite.fr/hal-03241408/document
Autor:
Rosa Montero-Macías, Marie Florin, Anne-Sophie Bats, Hélène Blons Hélène, Geraldine Perkins, Meriem Koual, Hélène Péré, Catherine Durdux, Simon Garinet, Marie Aude Le Frere-Belda, Huyen-Thu Nguyen-Xuan, Vincent Balay, Céline Crespel
Publikováno v:
Journal of Medical Case Reports
Journal of Medical Case Reports, 2021, 15 (1), pp.210. ⟨10.1186/s13256-021-02767-9⟩
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-5 (2021)
Journal of Medical Case Reports, 2021, 15 (1), pp.210. ⟨10.1186/s13256-021-02767-9⟩
Journal of Medical Case Reports, Vol 15, Iss 1, Pp 1-5 (2021)
Background Homologous recombination deficiency is a marker of response to poly(ADP-ribose) polymerase inhibitors in different cancer types including ovary, prostate, and pancreatic cancer. To date, no report about poly(ADP-ribose) polymerase inhibito
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8657d2883cefee843785435381cef057
https://doi.org/10.1186/s13256-021-02767-9
https://doi.org/10.1186/s13256-021-02767-9